Author
Colin R. Goding
University of OxfordORCID 0000-0002-1614-3909Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2023-2026 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 18 mutual co-author linksMutual co-authors in cluster
10 papers
Recent·Most cited
- Cell BiologybioRxivPreprint
Ciliary regulation of melanogenesis unveils moonlighting roles for Joubert Syndrome proteins
Brice Magne, Sara Forsey, Dawn C. Harper…·Michael S. Marks
The paper identifies ciliary proteins that regulate melanogenesis in melanocytes and reveals moonlighting roles for Joubert Syndrome proteins in endolysosomal organization.
- Cancer BiologyCell ReportsPeer-reviewed
Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.
Diogo Dias, Erica Aparecida de Oliveira, Román Martí-Díaz…·Colin R. Goding
The paper identifies distinct gene expression programs driven by MITF, TFEB, and TFE3 in melanoma, revealing their functional specialization in regulating differentiation, metabolism, and immune infiltration.
7 citations - Molecular BiologyNAR CancerPeer-reviewed
SETD6 Mediates Selective Interaction and Genomic Occupancy of BRD4 and MITF in Melanoma cells
Tzofit Elbaz Biton, Michal Feldman, Tomer Davidy…·Dan Levy
The paper investigates the role of SETD6 in mediating BRD4 and MITF interactions and genomic occupancy in melanoma cells, revealing a chromatin complex that regulates gene expression.
5 citations - Cancer BiologybioRxivPreprint
Metabolic buffering suppresses phenotype switching in cancer
Ana Ramírez-Sánchez, Miguel Jociles-Ortega, José Manuel García-Martínez…·Ana Chocarro‐Calvo
This study shows that glycogen storage and metabolic buffering suppress phenotype switching in melanoma, with low glycogen levels linked to invasion and poor survival.
DOI 10.1101/2025.04.07.647576 - Cancer BiologyPigment Cell & Melanoma ResearchPeer-reviewed
The lipid droplet protein DHRS3 is a regulator of melanoma cell state
Eleanor Johns, Yilun Ma, Pakavarin Louphrasitthiphol…·Richard Mark White
The paper identifies DHRS3 as a lipid droplet protein that regulates melanoma cell state by modulating retinoid signaling.
9 citations - Cancer BiologybioRxivPreprint
Systematic profiling of the acetyl lysine machinery reveals a role for MAPKAPK2 in bromodomain inhibitor resistance
Pata-Eting Kougnassoukou Tchara, Jérémy Loehr, Lucas Germain…·Jean‐Philippe Lambert
This study maps the acetyl lysine machinery interactions and identifies MAPKAPK2 as a factor contributing to resistance to BET bromodomain inhibitors in melanoma.
1 citation - Molecular BiologybioRxivPreprint
DNA damage-induced interaction between a lineage addiction oncogenic transcription factor and the MRN complex shapes a tissue-specific DNA Damage Response and cancer predisposition
Romuald Binet, Jean‐Philippe Lambert, Markéta Tomková…·Colin R. Goding
This study shows that the transcription factor MITF interacts with the MRN complex to modulate the DNA damage response in melanoma, contributing to cancer predisposition.
3 citations - GeneticsbioRxivPreprint
Loss of MC1R signaling implicates TBX3 in pheomelanogenesis and melanoma predisposition
H. Matthew Berns, Dawn E. Watkins‐Chow, Sizhu Lu…·William J. Pavan
The paper identifies TBX3 as a key regulator in pheomelanogenesis and melanoma predisposition through scRNA-seq analysis of RHC mouse models.